SJ
Sumer Jacquelyn l
Directeur Juridique et de Conformité
OtherF
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Sumer Jacquelyn l, Directeur Juridique et de Conformité. Insider active across 3 companies, notably Genocea Biosciences, INC.. Cumulatively, 16 reports have been published. Breakdown: 0 buy · 12 sells. Total volume traded: €210k. History available since 15 March 2022. The latest transaction was filed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Sumer Jacquelyn l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
3,601 股@ US$14.4723.9% 占其流量Common StockSEC:0001193125-26-071997:0
3,742 股@ US$13.6223.5% 占其流量Common StockSEC:0001193125-26-064255:0
3,480 股@ US$9.6729.5% 占其流量Common StockSEC:0001193125-25-327033:0
3,756 股@ US$8.5344.7% 占其流量Common StockSEC:0000950170-25-029197:0
50,000 股0Common StockSEC:0000950170-25-025030:0
3,482 股@ US$11.4155.3% 占其流量Common StockSEC:0000950170-24-139123:0
50,000 股0Common StockSEC:0000950170-24-019457:0
1,400 股@ US$8.5043.6% 占其流量Common StockSEC:0000950170-23-072755:0
290 股@ US$8.228.8% 占其流量Common StockSEC:0000950170-23-071986:0
291 股@ US$12.9413.8% 占其流量Common StockSEC:0000950170-23-029157:0
291 股@ US$8.769.5% 占其流量Common StockSEC:0000899243-23-013360:0
290 股@ US$10.7111.3% 占其流量Common StockSEC:0000950170-23-013697:0
305 股@ US$11.3213.0% 占其流量Common StockSEC:0000899243-23-009715:0
47,000 股0Common StockSEC:0000899243-23-005732:0
2,500 股@ US$0.0601100.0% 占其流量Common StockSEC:0001457612-22-000070:0
37,500 股0Common StockSEC:0001457612-22-000036:0
About Sumer Jacquelyn l
SUMER JACQUELYN L is Chief Legal Officer. She has filed 16 forms in total, and, across the sampled recent filings, the transactions are all sales, for a combined amount of EUR 209703, between 2022-03-17 and 2026-02-25. The recent filings concern Cullinan Therapeutics, Inc., Cullinan Oncology, Inc. and Genocea Biosciences, INC.